Literature DB >> 24795353

Long-term complete remission following radiosurgery and immunotherapy in a melanoma patient with brain metastasis: immunologic correlates.

Julia Karbach1, Sacha Gnjatic, Melina Biskamp, Akin Atmaca, Eckhart Weidmann, Kathrin Brandt, Claudia Wahle, Helga Bernhard, Alexander Knuth, Elke Jäger.   

Abstract

A melanoma patient with brain metastases was treated by gamma-knife radiosurgery and immunotherapy with autologous tumor-lysate-loaded dendritic cells (DC). Ten years after the combined treatment, the patient remains in complete remission. Remarkable immunologic correlates to the clinical development were the transient induction of NY-ESO-1 antibody and the durable expansion of MAGE-A1p161-169 EADPTGHSY-specific CD8+ T cells. Although the induction of NY-ESO-1 antibody most likely resulted from gamma-knife-mediated "auto-vaccination," the persistence of circulating MAGE-A1-specific T cells, which are still detectable ex vivo in the absence of any tumor manifestation, coincides with DC-based vaccination administered monthly until today.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24795353     DOI: 10.1158/2326-6066.CIR-13-0200

Source DB:  PubMed          Journal:  Cancer Immunol Res        ISSN: 2326-6066            Impact factor:   11.151


  5 in total

1.  Cancer Immunotherapy: From local to global.

Authors:  Willem J M Mulder; Sacha Gnjatic
Journal:  Nat Nanotechnol       Date:  2017-09-06       Impact factor: 39.213

Review 2.  Trial Watch: Radioimmunotherapy for oncological indications.

Authors:  Norma Bloy; Jonathan Pol; Gwenola Manic; Ilio Vitale; Alexander Eggermont; Jérôme Galon; Eric Tartour; Laurence Zitvogel; Guido Kroemer; Lorenzo Galluzzi
Journal:  Oncoimmunology       Date:  2014-12-13       Impact factor: 8.110

Review 3.  Immunotherapy and stereotactic ablative radiotherapy (ISABR): a curative approach?

Authors:  Michael B Bernstein; Sunil Krishnan; James W Hodge; Joe Y Chang
Journal:  Nat Rev Clin Oncol       Date:  2016-03-08       Impact factor: 66.675

Review 4.  Adverse Events of Oncologic Immunotherapy and Their Management.

Authors:  Fedricker Diane Barber
Journal:  Asia Pac J Oncol Nurs       Date:  2019 Jul-Sep

Review 5.  Harnessing nanomedicine for enhanced immunotherapy for breast cancer brain metastases.

Authors:  Christine P Carney; Nikhil Pandey; Anshika Kapur; Graeme F Woodworth; Jeffrey A Winkles; Anthony J Kim
Journal:  Drug Deliv Transl Res       Date:  2021-10-30       Impact factor: 4.617

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.